Skip to main content
Have a personal or library account? Click to login
Porphyria Cutanea Tarda – a Case Report Cover

Porphyria Cutanea Tarda – a Case Report

Serbian Journal of Dermatology and Venereology
Volume 5 (2013): Issue 3 (September 2013)
By: ,  ,  ,   and    
Open Access
|Mar 2014
References

References

  1. 1. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet 2010;375:924-37.
    Open DOISearch in Google Scholar
  2. 2. Frank J, Poblete-Gutiérrez P. Porphyria cutanea tarda-when skin meets liver. Best Pract Res Clin Gastroenterol 2010;24:735-45.
    Open DOISearch in Google Scholar
  3. 3. Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood 2012;120:4496-504.
    Open DOISearch in Google Scholar
  4. 4. Cappellini MD, Brancaleoni V, Graziadei G, Tavazzi D, Di Pierro E. Porphyrias at a glance: diagnosis and treatment. Intern Emerg Med 2010;5(Suppl 1):S73-S80.
    Open DOISearch in Google Scholar
  5. 5. Badenas C, To-Figueras J, Phillips JD, Warby CA, Munoz C, Herrero C. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Clin Genet 2009;75:346-53.
    Open DOISearch in Google Scholar
  6. 6. Bickers DR, Frank J. The porphyrias. In:Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller A, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw Hill; 2007. p. 1228-56.
    Search in Google Scholar
  7. 7. Waldenstrom J. Srudien uber porphyrie. Acta Med Scand 1937;82(Suppl):1-254.
    Search in Google Scholar
  8. 8. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CS, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 2000. p. 2991-3062.
    Search in Google Scholar
  9. 9. Bickers DR, Frank J. The porphyrias. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, et al. eds. Dermatology in general medicine. 6th ed. New York: McGraw Hill; 2003. p. 1435-66.
    Search in Google Scholar
  10. 10. de Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea: two different diseasesHum Genet 1978;44:145-51.
    Open DOISearch in Google Scholar
  11. 11. Elder GH, Lee GB, Tovey JA. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med 1978;299:274-8.
    Open DOISearch in Google Scholar
  12. 12. Felsher BF, Carpio NM, Engleking DW, Nunn AT. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tardaNew Engl J Med 1982;306:766-9.
    Open DOISearch in Google Scholar
  13. 13. Kushner J P, Barbuto AJ, Lee GR. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest 1976;58:1089-97.
    Open DOISearch in Google Scholar
  14. 14. Byrne JP, Boss JM, Dawber RP. Contaceptive pill-induced porphyria cutanea tarda presenting with onycholysis of the finger nail. Postgrad Med J 1976;52:535-8.
    Open DOISearch in Google Scholar
  15. 15. Taylor JS. Porphyria cutanea tarda symptomatica. Cutis 1970;6:1261-74.
    Search in Google Scholar
  16. 16. Boffa MJ, Reed P, Weinkove C, Ead RD. Hypertrichosis as the presenting feature of porphyria cutanea tarda. Clin Exp Dermatol 1995; 20:62-4.
    Open DOISearch in Google Scholar
  17. 17. Kapoor R, Johnson RA. Porphyria cutanea tarda and hypertrichosis. N Engl J Med 2013;360(14):1356.
    Open DOISearch in Google Scholar
  18. 18. Cripps DJ, Peters HA, Gocmen A, Dogramici I. Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients. Br J Dermatol 1984;111:413-22.
    Open DOISearch in Google Scholar
  19. 19. Haberman HF, Rosenberg F, Menon IA. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens. Can Med Assoc J 1975;113:653-5.
    Search in Google Scholar
  20. 20. Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon- alpha therapy in a case of chronic hepatitis C. Dig Dis Sci 1998;43:529-33.
    Open DOISearch in Google Scholar
  21. 21. Ashton RE, Hawk JL, Magnus IA. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. Br J Dermatol 1984;111:609-13.
    Open DOISearch in Google Scholar
  22. 22. Valls V, Ena J, Enriquez-De-Salamanca R. Low-dose oral chloroquine in patints with porphyria cutanea tarda and lowmoderate iron overload. J Dermatol Sci 1994;7:169-75.
    Open DOISearch in Google Scholar
  23. 23. Kordac V, Kotal JP, Kalab M. Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment. Semin Haematol 1989;26:16-23.
    Search in Google Scholar
  24. 24. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, Deleo VA, Harber LC. Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med 1979; 67:277-86.
    Open DOISearch in Google Scholar
  25. 25. Sarkany RP. The management of porphyria cutanea tarda. Clin Exp Dermatol 2001; 26:225-32.
    Open DOISearch in Google Scholar
  26. 26. Ghosh SK, Bandyopadhyay D, Chatterjee G, Ghosh AP. Porphyria cutanea tarda. J Assoc Physicians India 2008;56:441.
    Search in Google Scholar
  27. 27. Christoph S, Huttmann A, Duhrsen U, Roth A. Porphyria cutanea tarda. Br J Haematol 2010;148:493.
    Open DOISearch in Google Scholar
  28. 28. Stolzel U, Kostler E, Schuppan D, Richter M, Wollina U, Doss MO, et al. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 2003;139:309-13.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/sjdv-2013-0012 | Journal eISSN: 2406-0631 | Journal ISSN: 1821-0902
Journal RSS Feed
Language: English, Croatian
Page range: 141 - 148
Published on: Mar 7, 2014
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Porphyrias,
Estrogens + adverse effects,
Hypertrichosis,
Hair Removal,
Antimalarials
Related subjects:
Medicine,
Clinical medicine,
Dermatological and veneral diseases

© 2014 Tatjana Vukanović, Željko Mijušković, Lidija Kandolf-Sekulović, Lidija Zolotarevski, Radoš Zečević, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons License.

Volume 5 (2013): Issue 3 (September 2013)
Previous article